Tsun‐Leung Chan

433 total citations
17 papers, 296 citations indexed

About

Tsun‐Leung Chan is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Tsun‐Leung Chan has authored 17 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Tsun‐Leung Chan's work include BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (3 papers). Tsun‐Leung Chan is often cited by papers focused on BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (3 papers). Tsun‐Leung Chan collaborates with scholars based in Hong Kong, China and United States. Tsun‐Leung Chan's co-authors include Edmond S.K., Chun Hang Au, Karl A. Schellenberg, Ava Kwong, Vivian Y. Shin, Charles L. Wadkins, B. Thomas, Jiawei Chen, F. B. F. Law and James M. Ford and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Cancer.

In The Last Decade

Tsun‐Leung Chan

17 papers receiving 284 citations

Peers

Countries citing papers authored by Tsun‐Leung Chan

Since Specialization

Citations

This map shows the geographic impact of Tsun‐Leung Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsun‐Leung Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsun‐Leung Chan more than expected).

Fields of papers citing papers by Tsun‐Leung Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsun‐Leung Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsun‐Leung Chan. The network helps show where Tsun‐Leung Chan may publish in the future.

Co-authorship network of co-authors of Tsun‐Leung Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Tsun‐Leung Chan. A scholar is included among the top collaborators of Tsun‐Leung Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsun‐Leung Chan. Tsun‐Leung Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer? 2022 ·BMC Medical Genomics ·Ava Kwong, (unknown), Vivian Y. Shin, Chun Hang Au, Tsun‐Leung Chan, Edmond S.K.	11
2	Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong 2022 ·Vaccines ·(unknown), (unknown), (unknown), (unknown), (unknown), Tsun‐Leung Chan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	8
3	Germline mutations in Chinese ovarian cancer with or without breast cancer 2022 ·Molecular Genetics & Genomic Medicine ·Ava Kwong, (unknown), Vivian Y. Shin, Chun Hang Au, (unknown), (unknown), Tsun‐Leung Chan, Karen K. L. Chan, Hys Ngan, Edmond S.K.	7
4	Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients 2021 ·Cancers ·Ava Kwong, Vivian Y. Shin, (unknown), (unknown), Chun Hang Au, Karen K. L. Chan, Hys Ngan, Tsun‐Leung Chan, Edmond S.K.	9
5	Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients 2020 ·BMC Cancer ·Ava Kwong, Vivian Y. Shin, (unknown), Chun Hang Au, Thomas P. Slavin, Jeffrey N. Weitzel, Tsun‐Leung Chan, Edmond S.K.	8
6	Somatic mutation profiling in BRCA-negative breast and ovarian cancer patients by multigene panel sequencing. 2020 ·PubMed ·Ava Kwong, (unknown), Vivian Y. Shin, (unknown), Chun Hang Au, Dona N. Ho, (unknown), (unknown), Jiawei Chen, Karen K. L. Chan, Hys Ngan, Tsun‐Leung Chan, Edmond S.K.	10
7	Potential Utility of Metagenomic Sequencing for Improving Etiologic Diagnosis of Infective Endocarditis 2019 ·Future Cardiology ·(unknown), Chun Hang Au, (unknown), Dona N. Ho, Dinghua Li, Tsun‐Leung Chan, Tak‐Wah Lam, Edmond S.K., (unknown)	15
8	Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3 2019 ·Cancer ·Chunxiao Zhang, Stephen S.Y. Lam, Garret M. K. Leung, (unknown), Ning Yang, (unknown), (unknown), Chun Hang Au, Tsun‐Leung Chan, Edmond S.K., Sze‐Fai Yip, Harold K. K. Lee, June S. M. Lau, (unknown), (unknown), Yok‐Lam Kwong, Anskar Y.H. Leung	22
9	Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong 2018 ·BMC Infectious Diseases ·(unknown), Chun Hang Au, (unknown), Tsun‐Leung Chan, Edmond S.K., (unknown)	21
10	Draft Genome Sequence of Helicobacter cinaedi, Compiled by Direct Whole-Genome Sequencing of a Blood Culture-Positive Isolate in Hong Kong 2018 ·Microbiology Resource Announcements ·(unknown), Chun Hang Au, (unknown), Dona N. Ho, Tsun‐Leung Chan, Tak‐Wah Lam, Edmond S.K., (unknown)	2
11	Homoharringtonine (omacetaxine mepesuccinate) as an adjunct forFLT3-ITD acute myeloid leukemia 2016 ·Science Translational Medicine ·Stephen S.Y. Lam, (unknown), Bai‐Liang He, (unknown), (unknown), (unknown), (unknown), Harinder Gill, Alice M.S. Cheung, (unknown), C.C So, Jérôme Tamburini, Chi Wai Eric So, Dona N. Ho, Chun Hang Au, Tsun‐Leung Chan, Edmond S.K., Raymond Liang, Yok‐Lam Kwong, Anskar Y.H. Leung	51
12	The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer 2015 ·Cancer Genetics ·Ava Kwong, Jiawei Chen, Vivian Y. Shin, John Chi Wang Ho, F. B. F. Law, Chun Hang Au, Tsun‐Leung Chan, Edmond S.K., James M. Ford	43
13	Genetic predisposition of white matter infarction with protein S deficiency and R355C mutation 2010 ·Neurology ·Thomas Leung, Sze‐Fai Yip, (unknown), Tsun‐Leung Chan, Wynnie W.M. Lam, (unknown), Yu Fan, Natalie Pui Ha Chan, (unknown), (unknown), Ka Sing Wong	7
14	Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients 2000 ·International Journal of Cancer ·Judy Ho, Siu–Tsan Yuen, Lap-Ping Chung, (unknown), Tsun‐Leung Chan, Suet Yi Leung, Annie S.Y. Chan, (unknown), Polly W.Y. Lam, Ivy S.C. Luk	22
15	Detection of Fluoroquinolones in Urinary Specimens from Patients Undergoing Anti-Tuberculous Therapy 1997 ·Chemotherapy ·C. Y. Chan, Derek S. Tsang, Tsun‐Leung Chan, Wing Wai Yew, S.W. Cheung, (unknown)	1
16	The Formation and Isolation of an Arsenylated Component of Rat Liver Mitochondria 1969 ·Journal of Biological Chemistry ·Tsun‐Leung Chan, B. Thomas, Charles L. Wadkins	23
17	Studies on the Presence and Role of Tryptophan in Pig Heart Mitochondrial Malate Dehydrogenase 1968 ·Journal of Biological Chemistry ·Tsun‐Leung Chan, Karl A. Schellenberg	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact